Eyal Greenberg
Ramat Gan, TA 52626, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors.
Journal: Molecular cancer therapeutics
Published: November 27, 2025
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: April 25, 2020
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
Journal: Cell
Published: March 22, 2019
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
Journal: Cancer immunology, immunotherapy : CII
Published: August 29, 2017
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.
Journal: Oncotarget
Published: May 19, 2015
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
Journal: Oncotarget
Published: April 21, 2015
CEACAM1 promotes melanoma cell growth through Sox-2.
Journal: Neoplasia (New York, N.Y.)
Published: June 17, 2014
MicroRNAs in cancer: lessons from melanoma.
Journal: Current pharmaceutical design
Published: November 05, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: August 02, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
Journal: The Journal of clinical investigation
Published: January 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026